trump glp-1 announcement Fossbytes What Trump's GLP-1 weight-loss drug

et al., PNAS (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

Regulatory authorities allow foreign companies to set up their facilities in the region to serve the local population

Retatrutide, a triple agonist targeting gastric inhibitory polypeptide (GIP), GLP-1, and glucagon receptors, has achieved highly promising outcomes in its phase 2 trial [22], with weight loss up to 24%

It also protects liver health

At The Meadows, we are committed to responsible innovation and are carefully exploring this emerging area

Dr Thirunavukarasu warned that GLP-1 medications could be misused when taken without medical supervision, particularly by people using them for cosmetic weight loss rather than legitimate medical reasons